ID   LRP2_HUMAN              Reviewed;        4655 AA.
AC   P98164; O00711; Q16215;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 3.
DT   10-MAY-2017, entry version 176.
DE   RecName: Full=Low-density lipoprotein receptor-related protein 2;
DE            Short=LRP-2;
DE   AltName: Full=Glycoprotein 330;
DE            Short=gp330;
DE   AltName: Full=Megalin;
DE   Flags: Precursor;
GN   Name=LRP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-83.
RC   TISSUE=Kidney;
RX   PubMed=8706697; DOI=10.1111/j.1432-1033.1996.0132u.x;
RA   Hjaelm G., Murray E., Crumley G., Harazim W., Lundgren S., Onyango I.,
RA   Ek B., Larsson M., Juhlin C., Hellman P., Davis H., Aekerstroem G.,
RA   Rask L., Morse B.;
RT   "Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with
RT   potential intracellular signaling properties.";
RL   Eur. J. Biochem. 239:132-137(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2705-4453, AND VARIANTS GLU-4094 AND
RP   LEU-4210.
RC   TISSUE=Kidney;
RX   PubMed=7959795; DOI=10.1006/geno.1994.1348;
RA   Korenberg J.R., Argraves K.M., Chen X.N., Tran H., Strickland D.K.,
RA   Argraves W.S.;
RT   "Chromosomal localization of human genes for the LDL receptor family
RT   member glycoprotein 330 (LRP2) and its associated protein RAP
RT   (LRPAP1).";
RL   Genomics 22:88-93(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4139-4406.
RX   PubMed=8187828; DOI=10.1006/excr.1994.1153;
RA   Lundgren S., Hjaelm G., Hellman P., Ek B., Juhlin C., Rastad J.,
RA   Klareskog L., Aakerstroem G., Rask L.;
RT   "A protein involved in calcium sensing of the human parathyroid and
RT   placental cytotrophoblast cells belongs to the LDL-receptor protein
RT   superfamily.";
RL   Exp. Cell Res. 212:344-350(1994).
RN   [5]
RP   INTERACTION WITH LRPAP1.
RX   PubMed=1400426;
RA   Kounnas M.Z., Argraves W.S., Strickland D.K.;
RT   "The 39-kDa receptor-associated protein interacts with two members of
RT   the low density lipoprotein receptor family, alpha 2-macroglobulin
RT   receptor and glycoprotein 330.";
RL   J. Biol. Chem. 267:21162-21166(1992).
RN   [6]
RP   SUBUNIT, AND INTERACTION WITH CLU.
RX   PubMed=7768901; DOI=10.1074/jbc.270.22.13070;
RA   Kounnas M.Z., Loukinova E.B., Stefansson S., Harmony J.A.K.,
RA   Brewer B.H., Strickland D.K., Argraves W.S.;
RT   "Identification of glycoprotein 330 as an endocytic receptor for
RT   apolipoprotein J/clusterin.";
RL   J. Biol. Chem. 270:13070-13075(1995).
RN   [7]
RP   INTERACTION WITH DAB2.
RX   PubMed=10769163; DOI=10.1042/bj3470613;
RA   Oleinikov A.V., Zhao J., Makker S.P.;
RT   "Cytosolic adaptor protein Dab2 is an intracellular ligand of
RT   endocytic receptor gp600/megalin.";
RL   Biochem. J. 347:613-621(2000).
RN   [8]
RP   INTERACTION WITH LRP2BP.
RX   PubMed=12508107; DOI=10.1242/jcs.00243;
RA   Petersen H.H., Hilpert J., Militz D., Zandler V., Jacobsen C.,
RA   Roebroek A.J.M., Willnow T.E.;
RT   "Functional interaction of megalin with the megalin-binding protein
RT   (MegBP), a novel tetratrico peptide repeat-containing adaptor
RT   molecule.";
RL   J. Cell Sci. 116:453-461(2003).
RN   [9]
RP   INTERACTION WITH DAB2.
RX   PubMed=15134832; DOI=10.1016/j.biochi.2004.03.001;
RA   Gallagher H., Oleinikov A.V., Fenske C., Newman D.J.;
RT   "The adaptor disabled-2 binds to the third psi xNPxY sequence on the
RT   cytoplasmic tail of megalin.";
RL   Biochimie 86:179-182(2004).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-4272.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [11]
RP   VARIANT DBS HIS-2522.
RX   PubMed=17632512; DOI=10.1038/ng2063;
RA   Kantarci S., Al-Gazali L., Hill R.S., Donnai D., Black G.C.M.,
RA   Bieth E., Chassaing N., Lacombe D., Devriendt K., Teebi A.,
RA   Loscertales M., Robson C., Liu T., MacLaughlin D.T., Noonan K.M.,
RA   Russell M.K., Walsh C.A., Donahoe P.K., Pober B.R.;
RT   "Mutations in LRP2, which encodes the multiligand receptor megalin,
RT   cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.";
RL   Nat. Genet. 39:957-959(2007).
RN   [12]
RP   VARIANT ARG-103.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
RN   [13]
RP   VARIANT GLY-3828.
RX   PubMed=23992033; DOI=10.1111/cge.12265;
RA   Schrauwen I., Sommen M., Claes C., Pinner J., Flaherty M., Collins F.,
RA   Van Camp G.;
RT   "Broadening the phenotype of LRP2 mutations: a new mutation in LRP2
RT   causes a predominantly ocular phenotype suggestive of Stickler
RT   syndrome.";
RL   Clin. Genet. 86:282-286(2014).
RN   [14]
RP   VARIANT ASN-3779.
RX   PubMed=26529358; DOI=10.1097/YPG.0000000000000114;
RA   Vasli N., Ahmed I., Mittal K., Ohadi M., Mikhailov A., Rafiq M.A.,
RA   Bhatti A., Carter M.T., Andrade D.M., Ayub M., Vincent J.B., John P.;
RT   "Identification of a homozygous missense mutation in LRP2 and a
RT   hemizygous missense mutation in TSPYL2 in a family with mild
RT   intellectual disability.";
RL   Psychiatr. Genet. 26:66-73(2016).
CC   -!- FUNCTION: Acts together with cubilin to mediate HDL endocytosis
CC       (By similarity). May participate in regulation of parathyroid-
CC       hormone and para-thyroid-hormone-related protein release.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds plasminogen, extracellular matrix components,
CC       plasminogen activator-plasminogen activator inhibitor type I
CC       complex, apolipoprotein E-enriched beta-VLDL, lipoprotein lipase,
CC       lactoferrin, CLU/clusterin and calcium (PubMed:7768901). Forms a
CC       multimeric complex together with LRPAP1 (PubMed:1400426).
CC       Interacts (via PxLPxI/L motif) with ANKRA2 (via ankyrin repeats)
CC       (By similarity). Interacts with LRP2BP (PubMed:12508107).
CC       Interacts (via NPXY motif) with DAB2; the interaction is not
CC       affected by tyrosine phosphorylation of the NPXY motif
CC       (PubMed:10769163, PubMed:15134832). {ECO:0000250|UniProtKB:P98158,
CC       ECO:0000269|PubMed:10769163, ECO:0000269|PubMed:12508107,
CC       ECO:0000269|PubMed:1400426, ECO:0000269|PubMed:15134832,
CC       ECO:0000269|PubMed:7768901}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Membrane, coated pit.
CC   -!- TISSUE SPECIFICITY: Absorptive epithelia, including renal proximal
CC       tubules.
CC   -!- DOMAIN: Two overlapping PxLPxI/L motifs mediate interaction with
CC       ankyrin repeats of ANKRA2. {ECO:0000250|UniProtKB:P98158}.
CC   -!- DISEASE: Donnai-Barrow syndrome (DBS) [MIM:222448]: Rare autosomal
CC       recessive disorder characterized by major malformations including
CC       agenesis of the corpus callosum, congenital diaphragmatic hernia,
CC       facial dysmorphology, ocular anomalies, sensorineural hearing loss
CC       and developmental delay. The FOAR syndrome was first described as
CC       comprising facial anomalies, ocular anomalies, sensorineural
CC       hearing loss, and proteinuria. DBS and FOAR were first described
CC       as distinct disorders but the classic distinguishing features
CC       between the 2 disorders were presence of proteinuria and absence
CC       of diaphragmatic hernia and corpus callosum anomalies in FOAR.
CC       Early reports noted that the 2 disorders shared many phenotypic
CC       features and may be identical. Although there is variability in
CC       the expression of some features (e.g., agenesis of the corpus
CC       callosum and proteinuria), DBS and FOAR are now considered to
CC       represent the same entity. {ECO:0000269|PubMed:17632512}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the LDLR family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U33837; AAB41649.1; -; mRNA.
DR   EMBL; AC007556; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U04441; AAB02882.1; -; mRNA.
DR   EMBL; S73145; AAB30825.1; -; mRNA.
DR   CCDS; CCDS2232.1; -.
DR   PIR; I38467; I38467.
DR   PIR; I53413; I53413.
DR   RefSeq; NP_004516.2; NM_004525.2.
DR   UniGene; Hs.657729; -.
DR   PDB; 2M0P; NMR; -; A=1103-1148.
DR   PDBsum; 2M0P; -.
DR   ProteinModelPortal; P98164; -.
DR   SMR; P98164; -.
DR   BioGrid; 110216; 61.
DR   IntAct; P98164; 10.
DR   MINT; MINT-2860496; -.
DR   STRING; 9606.ENSP00000263816; -.
DR   DrugBank; DB00798; Gentamicin.
DR   DrugBank; DB00030; Insulin Human.
DR   DrugBank; DB00071; Insulin Pork.
DR   DrugBank; DB00013; Urokinase.
DR   iPTMnet; P98164; -.
DR   PhosphoSitePlus; P98164; -.
DR   BioMuta; LRP2; -.
DR   DMDM; 160332309; -.
DR   EPD; P98164; -.
DR   MaxQB; P98164; -.
DR   PaxDb; P98164; -.
DR   PeptideAtlas; P98164; -.
DR   PRIDE; P98164; -.
DR   Ensembl; ENST00000263816; ENSP00000263816; ENSG00000081479.
DR   GeneID; 4036; -.
DR   KEGG; hsa:4036; -.
DR   UCSC; uc002ues.4; human.
DR   CTD; 4036; -.
DR   DisGeNET; 4036; -.
DR   GeneCards; LRP2; -.
DR   GeneReviews; LRP2; -.
DR   H-InvDB; HIX0029894; -.
DR   HGNC; HGNC:6694; LRP2.
DR   HPA; HPA005980; -.
DR   HPA; HPA064792; -.
DR   MalaCards; LRP2; -.
DR   MIM; 222448; phenotype.
DR   MIM; 600073; gene.
DR   neXtProt; NX_P98164; -.
DR   OpenTargets; ENSG00000081479; -.
DR   Orphanet; 2143; Donnai-Barrow syndrome.
DR   PharmGKB; PA30452; -.
DR   eggNOG; KOG1215; Eukaryota.
DR   eggNOG; ENOG410XP34; LUCA.
DR   GeneTree; ENSGT00760000118968; -.
DR   HOGENOM; HOG000230574; -.
DR   HOVERGEN; HBG097941; -.
DR   InParanoid; P98164; -.
DR   KO; K06233; -.
DR   OMA; TRPPGMC; -.
DR   OrthoDB; EOG091G000N; -.
DR   PhylomeDB; P98164; -.
DR   TreeFam; TF315253; -.
DR   Reactome; R-HSA-196791; Vitamin D (calciferol) metabolism.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SignaLink; P98164; -.
DR   ChiTaRS; LRP2; human.
DR   GeneWiki; LRP2; -.
DR   GenomeRNAi; 4036; -.
DR   PRO; PR:P98164; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000081479; -.
DR   CleanEx; HS_LRP2; -.
DR   ExpressionAtlas; P98164; baseline and differential.
DR   Genevisible; P98164; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0030139; C:endocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042954; F:lipoprotein transporter activity; TAS:Reactome.
DR   GO; GO:0005041; F:low-density lipoprotein receptor activity; TAS:Reactome.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0035904; P:aorta development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0060976; P:coronary vasculature development; IEA:Ensembl.
DR   GO; GO:0006897; P:endocytosis; TAS:ProtInc.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   GO; GO:0042359; P:vitamin D metabolic process; TAS:Reactome.
DR   Gene3D; 2.120.10.30; -; 8.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR019825; Lectin_legB_Mn/Ca_BS.
DR   Pfam; PF12662; cEGF; 1.
DR   Pfam; PF07645; EGF_CA; 2.
DR   Pfam; PF00057; Ldl_recept_a; 34.
DR   Pfam; PF00058; Ldl_recept_b; 14.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00181; EGF; 26.
DR   SMART; SM00179; EGF_CA; 10.
DR   SMART; SM00192; LDLa; 36.
DR   SMART; SM00135; LY; 38.
DR   SUPFAM; SSF57184; SSF57184; 5.
DR   SUPFAM; SSF57424; SSF57424; 36.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 9.
DR   PROSITE; PS50026; EGF_3; 6.
DR   PROSITE; PS01187; EGF_CA; 3.
DR   PROSITE; PS01209; LDLRA_1; 31.
DR   PROSITE; PS50068; LDLRA_2; 36.
DR   PROSITE; PS51120; LDLRB; 35.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Coated pit; Complete proteome;
KW   Disease mutation; Disulfide bond; EGF-like domain; Endocytosis;
KW   Glycoprotein; Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; SH3-binding; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   4655       Low-density lipoprotein receptor-related
FT                                protein 2.
FT                                /FTId=PRO_0000017321.
FT   TOPO_DOM     26   4423       Extracellular. {ECO:0000255}.
FT   TRANSMEM   4424   4446       Helical. {ECO:0000255}.
FT   TOPO_DOM   4447   4655       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       26     64       LDL-receptor class A 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN       65    105       LDL-receptor class A 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      106    144       LDL-receptor class A 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      145    181       LDL-receptor class A 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      182    219       LDL-receptor class A 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      220    258       LDL-receptor class A 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      264    308       LDL-receptor class A 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN      309    347       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      348    386       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT      436    478       LDL-receptor class B 1.
FT   REPEAT      479    521       LDL-receptor class B 2.
FT   REPEAT      522    568       LDL-receptor class B 3.
FT   REPEAT      569    612       LDL-receptor class B 4.
FT   REPEAT      613    653       LDL-receptor class B 5.
FT   DOMAIN      659    705       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT      753    795       LDL-receptor class B 6.
FT   REPEAT      796    837       LDL-receptor class B 7.
FT   REPEAT      838    881       LDL-receptor class B 8.
FT   REPEAT      882    925       LDL-receptor class B 9.
FT   DOMAIN      970   1014       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1024   1062       LDL-receptor class A 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1065   1103       LDL-receptor class A 9.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1107   1145       LDL-receptor class A 10.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1147   1185       LDL-receptor class A 11.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1186   1224       LDL-receptor class A 12.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1228   1268       LDL-receptor class A 13.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1269   1307       LDL-receptor class A 14.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1310   1350       LDL-receptor class A 15.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1349   1389       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1390   1429       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REPEAT     1478   1520       LDL-receptor class B 10.
FT   REPEAT     1521   1563       LDL-receptor class B 11.
FT   REPEAT     1566   1609       LDL-receptor class B 12.
FT   REPEAT     1610   1654       LDL-receptor class B 13.
FT   REPEAT     1655   1695       LDL-receptor class B 14.
FT   DOMAIN     1700   1741       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1790   1832       LDL-receptor class B 15.
FT   REPEAT     1833   1882       LDL-receptor class B 16.
FT   REPEAT     1883   1930       LDL-receptor class B 17.
FT   REPEAT     1931   1971       LDL-receptor class B 18.
FT   REPEAT     1972   2013       LDL-receptor class B 19.
FT   DOMAIN     2018   2059       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     2107   2156       LDL-receptor class B 20.
FT   REPEAT     2157   2201       LDL-receptor class B 21.
FT   REPEAT     2202   2245       LDL-receptor class B 22.
FT   REPEAT     2246   2289       LDL-receptor class B 23.
FT   REPEAT     2290   2331       LDL-receptor class B 24.
FT   DOMAIN     2342   2383       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     2431   2477       LDL-receptor class B 25.
FT   REPEAT     2478   2518       LDL-receptor class B 26.
FT   REPEAT     2519   2562       LDL-receptor class B 27.
FT   REPEAT     2563   2603       LDL-receptor class B 28.
FT   REPEAT     2604   2646       LDL-receptor class B 29.
FT   DOMAIN     2651   2693       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     2698   2738       LDL-receptor class A 16.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2739   2777       LDL-receptor class A 17.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2778   2819       LDL-receptor class A 18.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2820   2861       LDL-receptor class A 19.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2862   2901       LDL-receptor class A 20.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2904   2945       LDL-receptor class A 21.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2946   2990       LDL-receptor class A 22.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     2991   3029       LDL-receptor class A 23.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3030   3070       LDL-receptor class A 24.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3073   3110       LDL-receptor class A 25.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3111   3151       EGF-like 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     3152   3192       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REPEAT     3239   3281       LDL-receptor class B 30.
FT   REPEAT     3282   3324       LDL-receptor class B 31.
FT   REPEAT     3333   3376       LDL-receptor class B 32.
FT   REPEAT     3377   3418       LDL-receptor class B 33.
FT   REPEAT     3419   3460       LDL-receptor class B 34.
FT   DOMAIN     3465   3509       EGF-like 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     3510   3550       LDL-receptor class A 26.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3551   3591       LDL-receptor class A 27.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3592   3632       LDL-receptor class A 28.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3633   3673       LDL-receptor class A 29.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3676   3716       LDL-receptor class A 30.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3717   3756       LDL-receptor class A 31.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3757   3795       LDL-receptor class A 32.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3796   3834       LDL-receptor class A 33.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3840   3880       LDL-receptor class A 34.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3881   3922       LDL-receptor class A 35.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3926   3964       LDL-receptor class A 36.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     3966   4006       EGF-like 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     4007   4048       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REPEAT     4154   4196       LDL-receptor class B 35.
FT   REPEAT     4197   4240       LDL-receptor class B 36.
FT   REPEAT     4242   4283       LDL-receptor class B 37.
FT   DOMAIN     4330   4368       EGF-like 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     4377   4411       EGF-like 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REGION     4589   4602       Interaction with DAB2.
FT   MOTIF      4453   4462       SH3-binding. {ECO:0000255}.
FT   MOTIF      4456   4461       PxLPxI/L motif 1; mediates interaction
FT                                with ANKRA2.
FT                                {ECO:0000250|UniProtKB:P98158}.
FT   MOTIF      4459   4464       PxLPxI/L motif 2; mediates interaction
FT                                with ANKRA2.
FT                                {ECO:0000250|UniProtKB:P98158}.
FT   MOTIF      4521   4526       Endocytosis signal. {ECO:0000255}.
FT   MOTIF      4593   4598       NPXY motif.
FT   MOTIF      4598   4601       SH2-binding. {ECO:0000255}.
FT   MOTIF      4611   4622       SH3-binding. {ECO:0000255}.
FT   METAL      1208   1208       Calcium. {ECO:0000250}.
FT   METAL      1210   1210       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL      1212   1212       Calcium. {ECO:0000250}.
FT   METAL      1218   1218       Calcium. {ECO:0000250}.
FT   METAL      1219   1219       Calcium. {ECO:0000250}.
FT   MOD_RES    4463   4463       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2ARV4}.
FT   MOD_RES    4466   4466       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2ARV4}.
FT   MOD_RES    4569   4569       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2ARV4}.
FT   MOD_RES    4616   4616       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P98158}.
FT   MOD_RES    4632   4632       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:A2ARV4}.
FT   MOD_RES    4653   4653       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2ARV4}.
FT   CARBOHYD    159    159       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    178    178       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    300    300       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    341    341       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    388    388       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    463    463       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    866    866       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1064   1064       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1144   1144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1186   1186       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1327   1327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1340   1340       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1383   1383       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1464   1464       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1496   1496       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1550   1550       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1675   1675       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1810   1810       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2055   2055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2177   2177       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2224   2224       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2499   2499       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2547   2547       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2781   2781       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2809   2809       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2810   2810       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2947   2947       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2987   2987       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3125   3125       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3211   3211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3257   3257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3315   3315       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3355   3355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3446   3446       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3564   3564       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3680   3680       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3978   3978       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4068   4068       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4327   4327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     28     40       {ECO:0000250}.
FT   DISULFID     35     53       {ECO:0000250}.
FT   DISULFID     47     62       {ECO:0000250}.
FT   DISULFID     67     80       {ECO:0000250}.
FT   DISULFID     74     93       {ECO:0000250}.
FT   DISULFID     87    103       {ECO:0000250}.
FT   DISULFID    108    120       {ECO:0000250}.
FT   DISULFID    115    133       {ECO:0000250}.
FT   DISULFID    127    142       {ECO:0000250}.
FT   DISULFID    147    157       {ECO:0000250}.
FT   DISULFID    152    170       {ECO:0000250}.
FT   DISULFID    164    179       {ECO:0000250}.
FT   DISULFID    183    195       {ECO:0000250}.
FT   DISULFID    190    208       {ECO:0000250}.
FT   DISULFID    202    217       {ECO:0000250}.
FT   DISULFID    222    234       {ECO:0000250}.
FT   DISULFID    229    247       {ECO:0000250}.
FT   DISULFID    241    256       {ECO:0000250}.
FT   DISULFID    266    279       {ECO:0000250}.
FT   DISULFID    273    292       {ECO:0000250}.
FT   DISULFID    286    307       {ECO:0000250}.
FT   DISULFID    312    321       {ECO:0000250}.
FT   DISULFID    317    330       {ECO:0000250}.
FT   DISULFID    332    346       {ECO:0000250}.
FT   DISULFID    352    362       {ECO:0000250}.
FT   DISULFID    358    371       {ECO:0000250}.
FT   DISULFID    373    385       {ECO:0000250}.
FT   DISULFID    663    674       {ECO:0000250}.
FT   DISULFID    670    689       {ECO:0000250}.
FT   DISULFID    691    704       {ECO:0000250}.
FT   DISULFID    974    988       {ECO:0000250}.
FT   DISULFID    984    998       {ECO:0000250}.
FT   DISULFID   1000   1013       {ECO:0000250}.
FT   DISULFID   1026   1038       {ECO:0000250}.
FT   DISULFID   1033   1051       {ECO:0000250}.
FT   DISULFID   1045   1060       {ECO:0000250}.
FT   DISULFID   1067   1079       {ECO:0000250}.
FT   DISULFID   1074   1092       {ECO:0000250}.
FT   DISULFID   1086   1101       {ECO:0000250}.
FT   DISULFID   1109   1121       {ECO:0000250}.
FT   DISULFID   1116   1134       {ECO:0000250}.
FT   DISULFID   1128   1143       {ECO:0000250}.
FT   DISULFID   1149   1161       {ECO:0000250}.
FT   DISULFID   1156   1174       {ECO:0000250}.
FT   DISULFID   1168   1183       {ECO:0000250}.
FT   DISULFID   1187   1200       {ECO:0000250}.
FT   DISULFID   1194   1213       {ECO:0000250}.
FT   DISULFID   1207   1222       {ECO:0000250}.
FT   DISULFID   1230   1243       {ECO:0000250}.
FT   DISULFID   1237   1256       {ECO:0000250}.
FT   DISULFID   1250   1266       {ECO:0000250}.
FT   DISULFID   1271   1283       {ECO:0000250}.
FT   DISULFID   1278   1296       {ECO:0000250}.
FT   DISULFID   1290   1305       {ECO:0000250}.
FT   DISULFID   1312   1325       {ECO:0000250}.
FT   DISULFID   1319   1338       {ECO:0000250}.
FT   DISULFID   1332   1348       {ECO:0000250}.
FT   DISULFID   1353   1364       {ECO:0000250}.
FT   DISULFID   1360   1373       {ECO:0000250}.
FT   DISULFID   1375   1388       {ECO:0000250}.
FT   DISULFID   1394   1404       {ECO:0000250}.
FT   DISULFID   1400   1413       {ECO:0000250}.
FT   DISULFID   1415   1428       {ECO:0000250}.
FT   DISULFID   1704   1713       {ECO:0000250}.
FT   DISULFID   1709   1725       {ECO:0000250}.
FT   DISULFID   1727   1740       {ECO:0000250}.
FT   DISULFID   2022   2033       {ECO:0000250}.
FT   DISULFID   2029   2043       {ECO:0000250}.
FT   DISULFID   2045   2058       {ECO:0000250}.
FT   DISULFID   2346   2357       {ECO:0000250}.
FT   DISULFID   2353   2368       {ECO:0000250}.
FT   DISULFID   2370   2382       {ECO:0000250}.
FT   DISULFID   2655   2666       {ECO:0000250}.
FT   DISULFID   2662   2675       {ECO:0000250}.
FT   DISULFID   2677   2692       {ECO:0000250}.
FT   DISULFID   2700   2712       {ECO:0000250}.
FT   DISULFID   2707   2725       {ECO:0000250}.
FT   DISULFID   2719   2736       {ECO:0000250}.
FT   DISULFID   2741   2753       {ECO:0000250}.
FT   DISULFID   2748   2766       {ECO:0000250}.
FT   DISULFID   2760   2775       {ECO:0000250}.
FT   DISULFID   2780   2793       {ECO:0000250}.
FT   DISULFID   2788   2806       {ECO:0000250}.
FT   DISULFID   2800   2817       {ECO:0000250}.
FT   DISULFID   2822   2835       {ECO:0000250}.
FT   DISULFID   2829   2848       {ECO:0000250}.
FT   DISULFID   2842   2859       {ECO:0000250}.
FT   DISULFID   2864   2876       {ECO:0000250}.
FT   DISULFID   2871   2889       {ECO:0000250}.
FT   DISULFID   2883   2899       {ECO:0000250}.
FT   DISULFID   2906   2918       {ECO:0000250}.
FT   DISULFID   2913   2931       {ECO:0000250}.
FT   DISULFID   2925   2943       {ECO:0000250}.
FT   DISULFID   2948   2965       {ECO:0000250}.
FT   DISULFID   2955   2978       {ECO:0000250}.
FT   DISULFID   2972   2988       {ECO:0000250}.
FT   DISULFID   2993   3005       {ECO:0000250}.
FT   DISULFID   3000   3018       {ECO:0000250}.
FT   DISULFID   3012   3027       {ECO:0000250}.
FT   DISULFID   3032   3044       {ECO:0000250}.
FT   DISULFID   3039   3057       {ECO:0000250}.
FT   DISULFID   3051   3068       {ECO:0000250}.
FT   DISULFID   3075   3087       {ECO:0000250}.
FT   DISULFID   3082   3100       {ECO:0000250}.
FT   DISULFID   3094   3109       {ECO:0000250}.
FT   DISULFID   3114   3126       {ECO:0000250}.
FT   DISULFID   3122   3135       {ECO:0000250}.
FT   DISULFID   3137   3150       {ECO:0000250}.
FT   DISULFID   3156   3167       {ECO:0000250}.
FT   DISULFID   3163   3176       {ECO:0000250}.
FT   DISULFID   3178   3191       {ECO:0000250}.
FT   DISULFID   3469   3480       {ECO:0000250}.
FT   DISULFID   3476   3491       {ECO:0000250}.
FT   DISULFID   3493   3508       {ECO:0000250}.
FT   DISULFID   3512   3525       {ECO:0000250}.
FT   DISULFID   3519   3538       {ECO:0000250}.
FT   DISULFID   3532   3548       {ECO:0000250}.
FT   DISULFID   3553   3565       {ECO:0000250}.
FT   DISULFID   3560   3578       {ECO:0000250}.
FT   DISULFID   3572   3589       {ECO:0000250}.
FT   DISULFID   3594   3606       {ECO:0000250}.
FT   DISULFID   3601   3619       {ECO:0000250}.
FT   DISULFID   3613   3630       {ECO:0000250}.
FT   DISULFID   3635   3647       {ECO:0000250}.
FT   DISULFID   3642   3660       {ECO:0000250}.
FT   DISULFID   3654   3671       {ECO:0000250}.
FT   DISULFID   3678   3692       {ECO:0000250}.
FT   DISULFID   3686   3705       {ECO:0000250}.
FT   DISULFID   3699   3714       {ECO:0000250}.
FT   DISULFID   3719   3732       {ECO:0000250}.
FT   DISULFID   3727   3745       {ECO:0000250}.
FT   DISULFID   3739   3754       {ECO:0000250}.
FT   DISULFID   3759   3771       {ECO:0000250}.
FT   DISULFID   3766   3784       {ECO:0000250}.
FT   DISULFID   3778   3793       {ECO:0000250}.
FT   DISULFID   3798   3810       {ECO:0000250}.
FT   DISULFID   3805   3823       {ECO:0000250}.
FT   DISULFID   3817   3832       {ECO:0000250}.
FT   DISULFID   3842   3854       {ECO:0000250}.
FT   DISULFID   3849   3867       {ECO:0000250}.
FT   DISULFID   3861   3878       {ECO:0000250}.
FT   DISULFID   3883   3896       {ECO:0000250}.
FT   DISULFID   3891   3909       {ECO:0000250}.
FT   DISULFID   3903   3920       {ECO:0000250}.
FT   DISULFID   3928   3940       {ECO:0000250}.
FT   DISULFID   3935   3953       {ECO:0000250}.
FT   DISULFID   3947   3962       {ECO:0000250}.
FT   DISULFID   3970   3979       {ECO:0000250}.
FT   DISULFID   3975   3989       {ECO:0000250}.
FT   DISULFID   3991   4005       {ECO:0000250}.
FT   DISULFID   4011   4021       {ECO:0000250}.
FT   DISULFID   4017   4030       {ECO:0000250}.
FT   DISULFID   4032   4047       {ECO:0000250}.
FT   DISULFID   4334   4342       {ECO:0000250}.
FT   DISULFID   4338   4351       {ECO:0000250}.
FT   DISULFID   4353   4367       {ECO:0000250}.
FT   DISULFID   4381   4389       {ECO:0000250}.
FT   DISULFID   4383   4399       {ECO:0000250}.
FT   DISULFID   4401   4410       {ECO:0000250}.
FT   VARIANT      83     83       N -> S (in dbSNP:rs2229263).
FT                                {ECO:0000269|PubMed:8706697}.
FT                                /FTId=VAR_037009.
FT   VARIANT     103    103       C -> R (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064727.
FT   VARIANT     259    259       G -> R (in dbSNP:rs34693334).
FT                                /FTId=VAR_061294.
FT   VARIANT     669    669       G -> D (in dbSNP:rs34291900).
FT                                /FTId=VAR_037010.
FT   VARIANT     909    909       H -> R (in dbSNP:rs36082715).
FT                                /FTId=VAR_037011.
FT   VARIANT    1083   1083       H -> Q (in dbSNP:rs2302691).
FT                                /FTId=VAR_037012.
FT   VARIANT    1279   1279       D -> A (in dbSNP:rs17848149).
FT                                /FTId=VAR_029182.
FT   VARIANT    1287   1287       A -> P.
FT                                /FTId=VAR_005421.
FT   VARIANT    2012   2012       R -> K (in dbSNP:rs4667596).
FT                                /FTId=VAR_029183.
FT   VARIANT    2065   2065       I -> T (in dbSNP:rs2228168).
FT                                /FTId=VAR_020218.
FT   VARIANT    2522   2522       Y -> H (in DBS; dbSNP:rs80338747).
FT                                {ECO:0000269|PubMed:17632512}.
FT                                /FTId=VAR_037013.
FT   VARIANT    2632   2632       N -> D (in dbSNP:rs17848169).
FT                                /FTId=VAR_029184.
FT   VARIANT    2872   2872       A -> T (in dbSNP:rs2228171).
FT                                /FTId=VAR_005422.
FT   VARIANT    3011   3011       R -> M (in dbSNP:rs11674973).
FT                                /FTId=VAR_037014.
FT   VARIANT    3305   3305       R -> H (in dbSNP:rs3213760).
FT                                /FTId=VAR_020219.
FT   VARIANT    3779   3779       D -> N (found in patients with mild
FT                                intellectual disability, unknown
FT                                pathological significance;
FT                                dbSNP:rs199583537).
FT                                {ECO:0000269|PubMed:26529358}.
FT                                /FTId=VAR_075534.
FT   VARIANT    3828   3828       D -> G (found in patients with a
FT                                phenotype suggestive of Stickler
FT                                syndrome; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:23992033}.
FT                                /FTId=VAR_075535.
FT   VARIANT    4094   4094       K -> E (in dbSNP:rs2075252).
FT                                {ECO:0000269|PubMed:7959795}.
FT                                /FTId=VAR_005423.
FT   VARIANT    4210   4210       I -> L (in dbSNP:rs4667591).
FT                                {ECO:0000269|PubMed:7959795}.
FT                                /FTId=VAR_005424.
FT   VARIANT    4272   4272       M -> V (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035996.
FT   CONFLICT   2724   2724       D -> G (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2773   2773       A -> T (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2827   2827       T -> P (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2880   2882       HWY -> TFGI (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2897   2897       A -> S (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2908   2908       A -> S (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2921   2921       S -> N (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2954   2954       L -> P (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2971   2972       VC -> PP (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2982   2982       Y -> H (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   2985   2985       N -> I (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   3615   3615       T -> S (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   3738   3738       Q -> K (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   3784   3784       C -> LW (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   3810   3810       C -> R (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   CONFLICT   4220   4220       R -> P (in Ref. 3; AAB02882).
FT                                {ECO:0000305}.
FT   STRAND     1111   1115       {ECO:0000244|PDB:2M0P}.
FT   STRAND     1121   1123       {ECO:0000244|PDB:2M0P}.
FT   STRAND     1129   1131       {ECO:0000244|PDB:2M0P}.
FT   STRAND     1133   1136       {ECO:0000244|PDB:2M0P}.
FT   HELIX      1138   1141       {ECO:0000244|PDB:2M0P}.
SQ   SEQUENCE   4655 AA;  521958 MW;  C73C4206B8B28CE0 CRC64;
     MDRGPAAVAC TLLLALVACL APASGQECDS AHFRCGSGHC IPADWRCDGT KDCSDDADEI
     GCAVVTCQQG YFKCQSEGQC IPNSWVCDQD QDCDDGSDER QDCSQSTCSS HQITCSNGQC
     IPSEYRCDHV RDCPDGADEN DCQYPTCEQL TCDNGACYNT SQKCDWKVDC RDSSDEINCT
     EICLHNEFSC GNGECIPRAY VCDHDNDCQD GSDEHACNYP TCGGYQFTCP SGRCIYQNWV
     CDGEDDCKDN GDEDGCESGP HDVHKCSPRE WSCPESGRCI SIYKVCDGIL DCPGREDENN
     TSTGKYCSMT LCSALNCQYQ CHETPYGGAC FCPPGYIINH NDSRTCVEFD DCQIWGICDQ
     KCESRPGRHL CHCEEGYILE RGQYCKANDS FGEASIIFSN GRDLLIGDIH GRSFRILVES
     QNRGVAVGVA FHYHLQRVFW TDTVQNKVFS VDINGLNIQE VLNVSVETPE NLAVDWVNNK
     IYLVETKVNR IDMVNLDGSY RVTLITENLG HPRGIAVDPT VGYLFFSDWE SLSGEPKLER
     AFMDGSNRKD LVKTKLGWPA GVTLDMISKR VYWVDSRFDY IETVTYDGIQ RKTVVHGGSL
     IPHPFGVSLF EGQVFFTDWT KMAVLKANKF TETNPQVYYQ ASLRPYGVTV YHSLRQPYAT
     NPCKDNNGGC EQVCVLSHRT DNDGLGFRCK CTFGFQLDTD ERHCIAVQNF LIFSSQVAIR
     GIPFTLSTQE DVMVPVSGNP SFFVGIDFDA QDSTIFFSDM SKHMIFKQKI DGTGREILAA
     NRVENVESLA FDWISKNLYW TDSHYKSISV MRLADKTRRT VVQYLNNPRS VVVHPFAGYL
     FFTDWFRPAK IMRAWSDGSH LLPVINTTLG WPNGLAIDWA ASRLYWVDAY FDKIEHSTFD
     GLDRRRLGHI EQMTHPFGLA IFGEHLFFTD WRLGAIIRVR KADGGEMTVI RSGIAYILHL
     KSYDVNIQTG SNACNQPTHP NGDCSHFCFP VPNFQRVCGC PYGMRLASNH LTCEGDPTNE
     PPTEQCGLFS FPCKNGRCVP NYYLCDGVDD CHDNSDEQLC GTLNNTCSSS AFTCGHGECI
     PAHWRCDKRN DCVDGSDEHN CPTHAPASCL DTQYTCDNHQ CISKNWVCDT DNDCGDGSDE
     KNCNSTETCQ PSQFNCPNHR CIDLSFVCDG DKDCVDGSDE VGCVLNCTAS QFKCASGDKC
     IGVTNRCDGV FDCSDNSDEA GCPTRPPGMC HSDEFQCQED GICIPNFWEC DGHPDCLYGS
     DEHNACVPKT CPSSYFHCDN GNCIHRAWLC DRDNDCGDMS DEKDCPTQPF RCPSWQWQCL
     GHNICVNLSV VCDGIFDCPN GTDESPLCNG NSCSDFNGGC THECVQEPFG AKCLCPLGFL
     LANDSKTCED IDECDILGSC SQHCYNMRGS FRCSCDTGYM LESDGRTCKV TASESLLLLV
     ASQNKIIADS VTSQVHNIYS LVENGSYIVA VDFDSISGRI FWSDATQGKT WSAFQNGTDR
     RVVFDSSIIL TETIAIDWVG RNLYWTDYAL ETIEVSKIDG SHRTVLISKN LTNPRGLALD
     PRMNEHLLFW SDWGHHPRIE RASMDGSMRT VIVQDKIFWP CGLTIDYPNR LLYFMDSYLD
     YMDFCDYNGH HRRQVIASDL IIRHPYALTL FEDSVYWTDR ATRRVMRANK WHGGNQSVVM
     YNIQWPLGIV AVHPSKQPNS VNPCAFSRCS HLCLLSSQGP HFYSCVCPSG WSLSPDLLNC
     LRDDQPFLIT VRQHIIFGIS LNPEVKSNDA MVPIAGIQNG LDVEFDDAEQ YIYWVENPGE
     IHRVKTDGTN RTVFASISMV GPSMNLALDW ISRNLYSTNP RTQSIEVLTL HGDIRYRKTL
     IANDGTALGV GFPIGITVDP ARGKLYWSDQ GTDSGVPAKI ASANMDGTSV KTLFTGNLEH
     LECVTLDIEE QKLYWAVTGR GVIERGNVDG TDRMILVHQL SHPWGIAVHD SFLYYTDEQY
     EVIERVDKAT GANKIVLRDN VPNLRGLQVY HRRNAAESSN GCSNNMNACQ QICLPVPGGL
     FSCACATGFK LNPDNRSCSP YNSFIVVSML SAIRGFSLEL SDHSETMVPV AGQGRNALHV
     DVDVSSGFIY WCDFSSSVAS DNAIRRIKPD GSSLMNIVTH GIGENGVRGI AVDWVAGNLY
     FTNAFVSETL IEVLRINTTY RRVLLKVTVD MPRHIVVDPK NRYLFWADYG QRPKIERSFL
     DCTNRTVLVS EGIVTPRGLA VDRSDGYVYW VDDSLDIIAR IRINGENSEV IRYGSRYPTP
     YGITVFENSI IWVDRNLKKI FQASKEPENT EPPTVIRDNI NWLRDVTIFD KQVQPRSPAE
     VNNNPCLENN GGCSHLCFAL PGLHTPKCDC AFGTLQSDGK NCAISTENFL IFALSNSLRS
     LHLDPENHSP PFQTINVERT VMSLDYDSVS DRIYFTQNLA SGVGQISYAT LSSGIHTPTV
     IASGIGTADG IAFDWITRRI YYSDYLNQMI NSMAEDGSNR TVIARVPKPR AIVLDPCQGY
     LYWADWDTHA KIERATLGGN FRVPIVNSSL VMPSGLTLDY EEDLLYWVDA SLQRIERSTL
     TGVDREVIVN AAVHAFGLTL YGQYIYWTDL YTQRIYRANK YDGSGQIAMT TNLLSQPRGI
     NTVVKNQKQQ CNNPCEQFNG GCSHICAPGP NGAECQCPHE GNWYLANNRK HCIVDNGERC
     GASSFTCSNG RCISEEWKCD NDNDCGDGSD EMESVCALHT CSPTAFTCAN GRCVQYSYRC
     DYYNDCGDGS DEAGCLFRDC NATTEFMCNN RRCIPREFIC NGVDNCHDNN TSDEKNCPDR
     TCQSGYTKCH NSNICIPRVY LCDGDNDCGD NSDENPTYCT THTCSSSEFQ CASGRCIPQH
     WYCDQETDCF DASDEPASCG HSERTCLADE FKCDGGRCIP SEWICDGDND CGDMSDEDKR
     HQCQNQNCSD SEFLCVNDRP PDRRCIPQSW VCDGDVDCTD GYDENQNCTR RTCSENEFTC
     GYGLCIPKIF RCDRHNDCGD YSDERGCLYQ TCQQNQFTCQ NGRCISKTFV CDEDNDCGDG
     SDELMHLCHT PEPTCPPHEF KCDNGRCIEM MKLCNHLDDC LDNSDEKGCG INECHDPSIS
     GCDHNCTDTL TSFYCSCRPG YKLMSDKRTC VDIDECTEMP FVCSQKCENV IGSYICKCAP
     GYLREPDGKT CRQNSNIEPY LIFSNRYYLR NLTIDGYFYS LILEGLDNVV ALDFDRVEKR
     LYWIDTQRQV IERMFLNKTN KETIINHRLP AAESLAVDWV SRKLYWLDAR LDGLFVSDLN
     GGHRRMLAQH CVDANNTFCF DNPRGLALHP QYGYLYWADW GHRAYIGRVG MDGTNKSVII
     STKLEWPNGI TIDYTNDLLY WADAHLGYIE YSDLEGHHRH TVYDGALPHP FAITIFEDTI
     YWTDWNTRTV EKGNKYDGSN RQTLVNTTHR PFDIHVYHPY RQPIVSNPCG TNNGGCSHLC
     LIKPGGKGFT CECPDDFRTL QLSGSTYCMP MCSSTQFLCA NNEKCIPIWW KCDGQKDCSD
     GSDELALCPQ RFCRLGQFQC SDGNCTSPQT LCNAHQNCPD GSDEDRLLCE NHHCDSNEWQ
     CANKRCIPES WQCDTFNDCE DNSDEDSSHC ASRTCRPGQF RCANGRCIPQ AWKCDVDNDC
     GDHSDEPIEE CMSSAHLCDN FTEFSCKTNY RCIPKWAVCN GVDDCRDNSD EQGCEERTCH
     PVGDFRCKNH HCIPLRWQCD GQNDCGDNSD EENCAPRECT ESEFRCVNQQ CIPSRWICDH
     YNDCGDNSDE RDCEMRTCHP EYFQCTSGHC VHSELKCDGS ADCLDASDEA DCPTRFPDGA
     YCQATMFECK NHVCIPPYWK CDGDDDCGDG SDEELHLCLD VPCNSPNRFR CDNNRCIYSH
     EVCNGVDDCG DGTDETEEHC RKPTPKPCTE YEYKCGNGHC IPHDNVCDDA DDCGDWSDEL
     GCNKGKERTC AENICEQNCT QLNEGGFICS CTAGFETNVF DRTSCLDINE CEQFGTCPQH
     CRNTKGSYEC VCADGFTSMS DRPGKRCAAE GSSPLLLLPD NVRIRKYNLS SERFSEYLQD
     EEYIQAVDYD WDPKDIGLSV VYYTVRGEGS RFGAIKRAYI PNFESGRNNL VQEVDLKLKY
     VMQPDGIAVD WVGRHIYWSD VKNKRIEVAK LDGRYRKWLI STDLDQPAAI AVNPKLGLMF
     WTDWGKEPKI ESAWMNGEDR NILVFEDLGW PTGLSIDYLN NDRIYWSDFK EDVIETIKYD
     GTDRRVIAKE AMNPYSLDIF EDQLYWISKE KGEVWKQNKF GQGKKEKTLV VNPWLTQVRI
     FHQLRYNKSV PNLCKQICSH LCLLRPGGYS CACPQGSSFI EGSTTECDAA IELPINLPPP
     CRCMHGGNCY FDETDLPKCK CPSGYTGKYC EMAFSKGISP GTTAVAVLLT ILLIVVIGAL
     AIAGFFHYRR TGSLLPALPK LPSLSSLVKP SENGNGVTFR SGADLNMDIG VSGFGPETAI
     DRSMAMSEDF VMEMGKQPII FENPMYSARD SAVKVVQPIQ VTVSENVDNK NYGSPINPSE
     IVPETNPTSP AADGTQVTKW NLFKRKSKQT TNFENPIYAQ MENEQKESVA ATPPPSPSLP
     AKPKPPSRRD PTPTYSATED TFKDTANLVK EDSEV
//
